DOCS Stock Recent News

Doximity has several things going its way, including its economic moat, high margins, and growth opportunities. Teladoc Health shares continue to fall even as the company has made tremendous progress in recent years.

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and Doximity (DOCS). But which of these two stocks presents investors with the better value opportunity right now?

Doximity's valuation and slowing sales growth are turning off many investors. Despite these issues, there is a lot to like about the company, including its moat.

Enphase is the cheapest it has ever been on a free-cash-flow basis. Toro hopes to restart sales growth, armed with a new Lowe's partnership.

Doximity is profitable and boasts high gross and net margins. The company's platform displays the flywheel effect, a powerful moat.

Doximity shares recently fell in response to a revised forward outlook management shared during its fiscal first-quarter earnings report. Over half a million unique U.S. physicians used Doximity's digital workflow tools during the three months ended June 30.

Doximity's revised guidance for the current fiscal year was horrendous. The business is still growing a bit and is highly profitable.

Doximity announced solid fiscal first-quarter 2024 results that exceeded expectations. But the online networking service for medical professionals is also laying off 10% of its workforce and lowered annual guidance.

Doximity said it was trimming its workforce by 10%. The company reported increased revenue and net income.

Doximity (NYSE: DOCS ) stock is falling hard on Wednesday after the medical cloud services company released earnings for its fiscal first quarter of 2024. The drop in DOCS stock is despite the company reporting adjusted earnings per share of 19 cents.